New surgery aims to eater eating for stomach cancer patients

NCT ID NCT07561073

Recruiting now Symptom relief Sponsor: Guangxi Medical University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 09, 2026 · Updated 3 times

Summary

This trial compares a new surgery called partial stomach-partitioning gastrojejunostomy (SPGJ) to the standard surgery for relieving stomach blockage in advanced gastric cancer. The goal is to see which surgery better helps patients eat normally, with fewer complications like delayed stomach emptying. About 80 adults with advanced cancer that cannot be removed will take part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: stomach-partitioning gastrojejunostomy (SPGJ) surgery
What this could lead to: If SPGJ works better than the standard surgery, it could offer a safer way to relieve stomach blockage, reduce complications, and improve quality of life for people with advanced gastric cancer.
What could go wrong: This is a small, early-stage trial with only 80 participants, so results may not apply to everyone. Both surgeries are invasive and carry risks like infection or bleeding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric cancer gastric neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTRIC CANCER

Contacts and locations

Locations

Guangxi Medical University Cancer Hospital
RECRUITING

Nanning, Guangxi, 530021, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.